Cardiovascular Effects Of Inhaled Ultrafine And Nanosized Particles Flemming R Cassee by Flemming R. Cassee, Nicholas L. Mills, David E. Newby 9780470433539, 9780470910917, 0470433531, 0470910917 instant download after payment.

This book assists scientists, toxicologists, clinicians, and public health regulators to understand the complex issues that determine the impact of air pollution on the cardiovascular system. It covers a range of relevant topics including particulate matter (PM) sources and characterization, methods of exposure, impact of PM on cells and systems, role of particles in the pathophysiology of cardiovascular disease, risk assessment, and potential environmental and therapeutic interventions.Content:
Chapter 1 Overview (pages 1–22): Flemming R. Cassee and Morton Lippmann
Chapter 2 Acute Effects of Particulate Matter on the Risk of Myocardial Infarction (pages 23–43): Krishnan Bhaskaran, Shakoor Hajat and Liam Smeeth
Chapter 3 Chronic Effects of Air Pollution on Cardiovascular Health (pages 45–57): Ranjini M. Krishnan, Joel Kaufman and Gerard Hoek
Chapter 4 Particle Characterization (pages 59–87): Thomas A. J. Kuhlbusch and Christof Asbach
Chapter 5 Exposure Assessment for Ambient Ultrafine Particles (pages 89–107): Timo Lanki, Josef Cyrys, H. ?Erich Wichmann and Jeroen de Hartog
Chapter 6 From Exposure to Dose (pages 109–124): Werner Hofmann and Bahman Asgharian
Chapter 7 Translocation of Inhaled Nanoparticles (pages 125–143): Wolfgang G. Kreyling, Winfried Moller, Otmar Schmid, Manuela Semmler?Behnke and Gunter Oberdorster
Chapter 8 Role of Chemical Composition in Determining the Cardiovascular Effects of Particles (pages 145–167): Andrew J. Ghio and Yuh?Chin T. Huang
Chapter 9 In Vitro Studies (pages 169–183): Per E. Schwarze and Gerrit M. Alink
Chapter 10 Experimental Studies in Animals (pages 185–215): Urmila P. Kodavanti, Lung?Chi Chen and Daniel L. Costa
Chapter 11 Human Exposure Studies (pages 217–239): Jeremy P. Langrish, Mark W. Frampton and Anders Blomberg
Chapter 12 Panel Studies (pages 241–248): Joel Schwartz
Chapter 13 Particulates and Oxidative Stress (pages 249–271): Steffen Loft, Roel P. F. Schins and Peter Moller
Chapter 14 Role of Inflammation in the Atherogenic Effects of Particulate Matter (pages 273–285): Thomas Sandstrom and David Newby
Chapter 15 Inhaled Particles, Postprandial Lipids, and their Possible Contribution to Atherogenesisc: The Trojan Horse Hypothesis (pages 287–293): Carlijne Hassing, Maarten J. M. Cramer and Marcel Th. B. Twickler
Chapter 16 Inhaled Particulate Matter and Atherosclerosis in Humans (pages 295–316): Barbara Hoffmann and Nino Kunzli
Chapter 17 Effects of Nanoparticles on the Pulmonary Vasculature (pages 317–350): Laurel E. Plummer, Kent E. Pinkerton, Amy K. Madl and Dennis W. Wilson
Chapter 18 Particulate Matter, Hypertension, and the Metabolic Syndrome (pages 351–377): Robert D. Brook and Sanjay Rajagopalan
Chapter 19 Particles and the Vascular Endothelium (pages 379–402): Nicholas L. Mills and Mark R. Miller
Chapter 20 Particles, Coagulation, and Thrombosis (pages 403–420): Evren Kilinc, Goran Rudez, Henri M. H. Spronk, Abderrahim Nemmar, Moniek P. M. de Maat, Hugo ten Cate and Marc F. Hoylaerts
Chapter 21 Particles and the Pathogenesis of Atherothrombosis (pages 421–437): Qinghua Sun and Xiaohua Xu
Chapter 22 Particles and the Autonomic Nervous System (pages 439–466): Swapna Upadhyay, Alison Elder, Wayne E. Cascio and Holger Schulz
Chapter 23 Air Pollution and Arrhythmia (pages 467–482): Helen C. Routledge and Jonathan N. Townend
Chapter 24 Risk Assessment (pages 483–496): Robert L. Maynard and Jon G. Ayres
Chapter 25 Environmental Regulation of Particulate Matter (pages 497–523): Richard Damberg, Klaas Krijgsheld, May Ajero and Sophie Punte
Chapter 26 From Ambient Ultrafine Particles to Nanotechnology and Nanotoxicology (pages 525–543): Ken Donaldson and David B. Warheit